OS Therapies Incorporated – Material Contracts Watch

from 8-K 14 pages Pledge and Security Agreement

from 8-K 35 pages Securities Purchase Agreement

from 8-K 10 pages Settlement Agreement and Mutual Release

from 8-K/A 3 pages OS Therapies Incorporated, a Delaware Corporation (The “Company”), Certain Wholly Owned Subsidiaries of the Company and Leonite Fund I, LP, a Delaware Limited Partnership (The “Investor”), Are Parties to That Certain Securities Purchase Agreement, Dated as of June 30, 2026 (The “Purchase Agreement”), Pursuant to Which the Company Agreed To, Among Other Things, Issue to the Investor (I) a Senior Secured Convertible Promissory Note in the Principal Amount of Up to $10,000,000 (The “Note”), to Be Funded in One or More Tranches, and (II) a Warrant to Purchase Up to 1,750,000 Shares of the Company’s Common Stock (The “Warrant” And, Collectively With the Note, the Purchase Agreement and the Other Agreements, Instruments and Documents Delivered in Connection Therewith, the “Transaction Documents”). Capitalized Terms Used but Not Otherwise Defined Herein Shall Have the Meanings Ascribed to Such Terms in the Note, the Warrant or the Purchase Agreement, as Applicable

from 8-K 16 pages Pledge and Security Agreement

from 8-K 22 pages Securities Purchase Agreement

from 8-K 47 pages Securities Purchase Agreement Article 1. Definitions

from 8-K 43 pages Securities Purchase Agreement

from 8-K 12 pages Certain Holders of Common Stock Purchase Warrants Issued in Connection With Warrant Exercise Inducement and Exchange Offerings Re: Inducement Offer to Exercise or Pre-Fund Common Stock Purchase Warrants Dear Holder

from 8-K 23 pages OS Therapies Incorporated 2023 Incentive Compensation Plan OS Therapies Incorporated 2023 Incentive Compensation Plan

from 8-K 9 pages Holder of Common Stock Purchase Warrants Issued on December 31, 2024 and/or January 14, 2025 Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder

from 8-K 9 pages Holder of Common Stock Purchase Warrants Issued on December 31, 2024 and/or January 14, 2025 Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder

from 8-K 19 pages Registration Rights Agreement

from 8-K 15 pages Asset Purchase Agreement

from 8-K 5 pages Amendment No. 1 to Securities Purchase Agreement and Amendment to Registration Rights Agreement

from 8-K 16 pages Letter Agreement, Dated December 27, 2024, by and Between Os Therapies Incorporated and Brookline Capital Markets, a Division of Arcadia Securities, LLC

from 8-K 9 pages Voting Agreement

from 8-K 22 pages Registration Rights Agreement

from 8-K 47 pages Securities Purchase Agreement

from 8-K 15 pages Registration Rights Agreement